Strive Health expands partnership with Illinois nephrology group
Click Here to Manage Email Alerts
Strive Health is expanding its relationship with Nephrology Associates of Northern Illinois and Indiana to help manage up to 20,000 patients with kidney disease, according to a company press release.
Strive Health said it was building on its partnership with Nephrology Associates of Northern Illinois and Indiana (NANI) announced in 2021. The companies have agreed to more than double the length of the alliance to 10 years.
“Our approach to kidney care has yielded compelling results, helping to delay the progression of the disease, reducing costs and improving the patient experience,” Chris Riopelle, Strive Health CEO and co-founder, said. “Given our success, it only makes sense to broaden our scope to reach more patients who we know will benefit from a value-based model.”
NANI employs more than 140 nephrologists in Indiana and Illinois.
“Strive’s solution is integrated into our members’ practices, giving them the tools and infrastructure needed to succeed in a value-based contract,” Brian O’Dea, CEO of NANI, said in the release. “NANI’s mission has always been to put the patient at the center of the care model and make it as easy as possible for each patient to receive what they need to manage their condition effectively and achieve better health outcomes. Our partnership with Strive makes it possible to achieve that goal.”
Strive Health will help NANI manage Medicare and Medicare Advantage plan members with chronic kidney disease and end-stage kidney disease. As part of the expanded partnership, NANI is also increasing its equity investment in Strive Health.
“Strive and NANI will also conduct outcomes-oriented clinical research on the effectiveness of interventions in reducing costs in value-based contracting models,” according to the release. “The research will help further the nephrology industry’s understanding of which interventions can improve outcomes and drive down costs and offer more insight into how new contracting arrangements, such as Medicare’s Comprehensive Kidney Care Contracting (CKCC) model, can delay the progression of kidney disease.”